Spatial Omics Global Market Report 2024

The spatial omics market size has grown rapidly in recent years. It will grow from $0.27 billion in 2023 to $0.3 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth observed in the historic period can be attributed to several factors, including the rising prevalence of genetic disorders, an increase in cancer cases, growing demand for personalized medicine, the need for biomarker identification and validation, as well as the increasing adoption of spatial genomics, transcriptomics, and proteomics technologies.

The spatial omics market size is expected to see rapid growth in the next few years. It will grow to $0.46 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The forecasted growth can be attributed to increased research and development activities, enhanced financing for OMICS research, the development of transformative approaches for discovering cancer biomarkers, increased focus on translational research, and overall economic growth. Major trends expected in the forecast period include strategic collaborations and partnerships, the adoption of spatial omics techniques, integration of advanced technologies, product innovations, and technological advancements.

The increasing prevalence of genetic disorders is set to drive the growth of the spatial omics market. Genetic illnesses are conditions resulting from abnormalities in an individual's DNA inherited from one or both parents. The rise in genetic diseases is attributed to heightened awareness, improved diagnostic methods, lifestyle shifts, and environmental factors contributing to genetic mutations. Spatial omics technologies offer a potent approach to studying genetic disorders by providing detailed spatial maps of molecular and genetic characteristics within tissues. For instance, in February 2023, the World Health Organization (WHO) reported that congenital diseases caused approximately 240,000 infant deaths globally within the first 28 days of birth annually. Additionally, the Centers for Disease Control and Prevention (CDC) noted that about 6,000 babies are born with Down syndrome in the United States each year, equating to approximately 1 in every 700 births. Consequently, the increasing incidence of genetic diseases is propelling the spatial omics market's expansion.

Key players in the spatial omics market are innovating with advanced technologies, such as novel spatial omics platforms, to strengthen their market presence. Spatial omics platforms are integrated systems or technologies designed to facilitate the analysis of molecular characteristics within tissues or cells' spatial context. For instance, in March 2021, Rebus Biosystems Inc., a US-based life science technology company, introduced the Rebus Esper spatial omics platform. This platform leverages Synthetic Aperture Optics (SAO) technology to deliver high-throughput, quantitative, single-molecule, single-cell data with spatial context and subcellular resolution. This innovative platform enables researchers to delve into tissue biology with unprecedented detail by analyzing millions of cellular features across tissues routinely, thereby enhancing spatial analysis precision and depth.

In May 2024, Bruker Corporation, a US-based manufacturer of scientific equipment for materials and molecular biology research, acquired NanoString Technologies Inc.'s business for approximately $392.6 million in cash. This acquisition aims to broaden Bruker's spatial biology portfolio by incorporating gene expression profiling and spatial transcriptomics solutions and products. NanoString Technologies Inc. is a US-based company specializing in molecular diagnostic products and life science tools for translational research.

Major companies operating in the spatial omics market are Agilent Technologies Inc., PerkinElmer Inc., Ilumina Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Luminex Corporation, Takara Bio Inc., Oxford Nanopore Technologies, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., CrestOptics, Indica Labs Inc., Miroculus Inc., Resolve Biosciences GmbH, Pixelgen Technologies, Ionpath Inc., RareCyte Inc., S2 Genomics Inc., Spatial Genomics, Vizgen Inc., BioSpyder Technologies, Ultivue Inc., Seven Bridges Genomics.

North America was the largest region in the Spatial OMICS market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spatial omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spatial omics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Spatial omics is a multidisciplinary domain that combines spatial analysis techniques with omics technologies, enabling the visualization and analysis of biomolecules within their spatial context in tissues. This field serves as a potent tool by merging spatial and molecular data to offer a comprehensive understanding of the organization and functionality of biological systems.

The primary products in the spatial omics market include instruments, consumables, and software. Spatial transcriptomics, for instance, is a technology enabling scientists to examine gene expression patterns within tissue or cells, providing spatial insights into gene activity. Various sample types, such as formalin-fixed paraffin-embedded (FFPE) and fresh frozen samples, are utilized, with workflows encompassing sample preparation, instrumental analysis, and data analysis. Technologies such as spatial transcriptomics, spatial genomics, and spatial proteomics find application across end-users such as academic and translational research institutes, as well as pharmaceutical and biotechnology companies.

The spatial omics market research report is one of a series of new reports that provides spatial omics market statistics, including spatial omics industry global market size, regional shares, competitors with a spatial omics market share, detailed spatial omics market segments, market trends, and opportunities, and any further data you may need to thrive in the spatial omics industry. This spatial omics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The spatial omics market includes revenues earned by entities by providing services such as spatial epigenomics, single-cell spatial analysis, spatial lipidomics and metabolomics, and multi-omics integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The spatial omics market consists of sales of spatial omics instrumentation, imaging systems, and imaging mass spectrometry. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.